Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03711695 · ClinicalTrials.gov registry record
iBeat Wristwatch Validation Study
A clinical trial of Arrythmia, Cardiac, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 55
- Enrollment target
- 1
- Study location
NCT03711695: Completed study of Arrythmia, Cardiac, sponsored by University of California, San Francisco.
NCT03711695 is a study of Arrythmia, Cardiac that has completed, run by University of California, San Francisco. The registered enrollment target is 55 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03711695, a study of Arrythmia, Cardiac, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 55 participants
- Enrollment target
- 1
- Study location
Study Summary
The iBeat Study is a single-center, prospective, unblinded validation of the photoplethysmography (PPG) and tissue oximetry (TO) signal waveforms recorded from a wrist-based sensor devices.
Primary Outcome
Detect hemodynamic significant arrhythmia using changes in photoplethysmography \[PPG\] as measured using a wrist-watch.
Conditions Studied
Interventions
- DEVICE iBeat wristwatch device
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2018-03-22 |
| Est. Completion | 2018-12-30 |
What the finished NCT03711695 record still lists
NCT03711695 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 55 participants, a relatively small participant target.
The record links to 1 condition, with Arrythmia, Cardiac appearing as the primary indexed condition, and to 1 intervention - of which iBeat wristwatch device is the first listed.
NCT03711695 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03711695 about?
NCT03711695 is a clinical study titled "iBeat Wristwatch Validation Study". The iBeat Study is a single-center, prospective, unblinded validation of the photoplethysmography (PPG) and tissue oximetry (TO) signal waveforms recorded from a wrist-based sensor devices.
What is the current status of trial NCT03711695?
This trial is currently completed. The enrollment target is 55 participants. The study started on 2018-03-22. Estimated completion is 2018-12-30.
What conditions does trial NCT03711695 study?
This clinical trial studies the following conditions: Arrythmia, Cardiac.
What interventions are being tested in trial NCT03711695?
The interventions under investigation include: iBeat wristwatch device (DEVICE).
Who is sponsoring clinical trial NCT03711695?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03711695 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI